Kaplin Adam 4
4 · MyMD Pharmaceuticals, Inc. · Filed Apr 21, 2021
Insider Transaction Report
Form 4
Kaplin Adam
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-16+154,360→ 154,360 totalExercise: $2.59Exp: 2023-04-16→ Common Stock (154,360 underlying)
Footnotes (2)
- [F1]Received in exchange for a stock option to acquire 400,000 shares of common stock of a private company formerly known as "MyMD Pharmaceuticals, Inc." (the "Former Entity") at $1.00 per share in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share.
- [F2]These options are fully vested and exercisable.